| Title | Whole genome analysis of the action of interferon-beta. | | Author(s) | Kauffman MA, Yankilevich P, Barrero P, Bello R, Marangunich L, Vidal A, Criscuolo M, Diez RA, Sterin Prync A | | Institution | 1Bio Sidus SA, Buenos Aires, Argentina, and 2Laboratorio de Virología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. | | Source | Int J Clin Pharmacol Ther 2009 May; 47(5):328-57. | | Abstract | Objectives: To characterize the IFNbeta1a-regulated gene expression on leukocytes of Multiple Sclerosis (MS) patients using microarrays with whole human genome representation.
Methods: Genes differentially expressed by interferon-beta were identified by a microarray in vitro study performed in leukocytes obtained from 5 MS relapsing-remitting patients.
Results: Following the culture of peripheral blood mononuclear cells from MS relapsing-remitting patients for 24 hs with IFNbeta1a, the expression of 868 genes was modified: 545 increased (including CXCL11, CCL8, INDO, IFI27, CFB, CXCL10 and IFIT1) and 323 diminished (including RBP7, SEPT5, RNF8, ADORA2B and FOS).
Conclusions: Since many of them were previously recognized as involved in MS pathogenesis, the IFNbeta1a mechanism of action could imply a compensatory regulation of systems deregulated in MS. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19473595 |
|
